id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3572-0001,FDA,FDA-2024-E-3572,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:19:54Z,,0,0,090000648660e09d
FDA-2024-E-3572-0003,FDA,FDA-2024-E-3572,Requirement for Information,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:21:37Z,,0,0,090000648660e09f
FDA-2024-E-3572-0002,FDA,FDA-2024-E-3572,Patent Extension Application from Foley & Lardner LLP (on behalf of BeiGene Switzerland GmbH),Other,Application,2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:21:32Z,,0,0,090000648660e09e